| # | Drug | Count |
|---|---|---|
| 0 | INTERFERON BETA-1A | 87 |
| 1 | ALBUTEROL SULFATE | 68 |
| 2 | GLATIRAMER ACETATE | 66 |
| 3 | ETANERCEPT | 63 |
| 4 | OMALIZUMAB | 60 |
| 5 | MONTELUKAST SODIUM | 56 |
| 6 | ASPIRIN | 48 |
| 7 | ASPIRIN 325 MG | 48 |
| 8 | ASPIRIN 81 MG | 48 |
| 9 | ADALIMUMAB | 47 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZETHONIUM CHLORIDE 0.13% | 1 | 0.0152 |
| 1 | CAFFEINE, MAGNESIUM SALICYLATE | 1 | 0.0039 |
| 2 | MINERAL OIL, WHITE PETROLATUM | 1 | 0.0035 |
| 3 | PAMABROM | 1 | 0.0027 |
| 4 | SPESOLIMAB | 1 | 0.0025 |
| 5 | TOPICAL ANESTHETIC | 2 | 0.0025 |
| 6 | GINKGO BILOBA | 3 | 0.0021 |
| 7 | BENZOCAINE | 2 | 0.0020 |
| 8 | NIVOLUMAB AND RELATLIMAB-RMBW | 1 | 0.0019 |
| 9 | CAPLACIZUMAB | 3 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 93 |
| 1 | Interferon beta [EPC] | 90 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 70 |
| 3 | GLP-1 Receptor Agonist [EPC] | 62 |
| 4 | Anti-IgE [EPC] | 60 |
| 5 | Corticosteroid [EPC] | 58 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 50 |
| 7 | Prostacycline Vasodilator [EPC] | 47 |
| 8 | Interleukin-4 Receptor alpha Antagonist [EPC] | 45 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 34 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 10 | 0.0145 |
| 1 | Cytolytic Agent [EPC] | 11 | 0.0047 |
| 2 | Interleukin-36 Receptor Antagonist [EPC] | 1 | 0.0025 |
| 3 | Adrenocorticotropic Hormone [EPC] | 2 | 0.0022 |
| 4 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 5 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 6 | Non-Standardized House Dust Allergenic Extract [EPC] | 1 | 0.0013 |
| 7 | PCSK9 Inhibitor [EPC] | 32 | 0.0012 |
| 8 | Standardized Animal Hair Allergenic Extract [EPC] | 1 | 0.0012 |
| 9 | Provitamin D2 Compound [EPC] | 32 | 0.0011 |